tiprankstipranks
Trending News
More News >
Swiss Re AG (CH:SREN)
:SREN

Swiss Re AG (SREN) AI Stock Analysis

Compare
32 Followers

Top Page

CH:SREN

Swiss Re AG

(SREN)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
,
Outperform 70 (OpenAI - 5.2)
,
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
CHF142.00
▲(10.94% Upside)
Action:UpgradedDate:03/16/26
The score is driven primarily by improving financial performance (stronger profitability, ROE, and lower leverage) and supported by attractive valuation (low P/E and strong dividend yield). These positives are tempered by weaker longer-term technical positioning (below 100/200-day averages) and some volatility in revenue and cash-flow trends.
Positive Factors
Profitability Rebound & Margins
Swiss Re's net income and margins materially improved into 2025, reflecting stronger underwriting and investment outcomes. Sustained higher profitability increases retained earnings, strengthens ROE and bolsters the company's capacity to fund claims, capital needs and shareholder distributions over the medium term.
Improved Balance Sheet / Lower Leverage
Leverage reduction and equity growth materially improve financial flexibility and loss-absorption capacity. Lower debt-to-equity supports larger underwriting capacity, reduces refinancing and solvency risk, and provides a stronger base for navigating catastrophe losses and regulatory capital requirements over coming quarters.
Diversified Business Mix & Float
Swiss Re's multi-line model (P&C, L&H, Corporate Solutions) plus investment income on float and ILS/structured solutions provides multiple durable revenue streams. Diversification across product lines and fee/investment income reduces dependence on a single cycle and supports steadier long-term cash generation.
Negative Factors
Revenue & Cash-flow Volatility
Swiss Re's top-line has swung year-to-year with declines and rebounds across 2023–2025. Persistent revenue volatility complicates underwriting capacity planning, long-range pricing strategy and predictability of earnings, making multi-quarter forecasting and capital allocation riskier for investors and management.
Inconsistent Cash-Flow-to-Earnings Conversion
Operating cash flows are positive (~3.1B in 2024; ~3.2B in 2025), yet uneven free cash flow growth and weak cash-flow-to-earnings conversion reduce reliability of internal funding. This inconsistency can constrain dividends, buybacks or reserves accumulation when underwriting volatility rises.
Cyclicality & Catastrophe Exposure
Swiss Re operates in a structurally cyclical industry where reinsurance pricing and catastrophe frequency drive large earnings swings. This inherent exposure can create episodic capital strain and earnings pressure, requiring sustained underwriting discipline and capital buffers across multi-year cycles.

Swiss Re AG (SREN) vs. iShares MSCI Switzerland ETF (EWL)

Swiss Re AG Business Overview & Revenue Model

Company DescriptionSwiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
How the Company Makes MoneySwiss Re makes money primarily by assuming insurance risk for a premium and by earning investment income on the capital (“float”) it holds to pay future claims. 1) Reinsurance underwriting (core): - P&C Reinsurance: Swiss Re sells reinsurance protection to primary insurers covering catastrophe and non-catastrophe risks (e.g., natural catastrophes, large industrial losses, motor and general liability portfolios). Revenue is largely premium income; profitability depends on pricing/terms, loss experience (including catastrophe events), reserving accuracy, and disciplined risk selection and diversification. - L&H Reinsurance: Swiss Re reinsures mortality, morbidity, longevity, disability, and health-related risks for life and health insurers. It earns premiums and fees tied to reinsured policies and can generate stable results when claims and experience assumptions (mortality/morbidity/longevity) track expectations. 2) Primary commercial insurance (Corporate Solutions): - Swiss Re also writes direct (primary) commercial insurance for corporate clients, typically in specialty and large-risk segments. It earns insurance premiums directly from insureds (often distributed through brokers) and generates underwriting profit when premiums exceed claims, commissions, and operating expenses. 3) Investment income and capital management: - Premiums are collected upfront and invested until claims are paid. Swiss Re earns net investment income (interest, dividends) and may realize gains/losses from its investment portfolio. Returns are influenced by asset allocation, credit and market conditions, and interest-rate levels. 4) Fee-based and structured/insurance-linked solutions: - Swiss Re provides risk-transfer structures and may participate in insurance-linked securities (ILS) and other structured solutions that can generate fee income and/or underwriting-related earnings depending on structure and retained risk. Key factors affecting earnings: - Pricing cycles in reinsurance markets (hard/soft markets) and renewal terms. - Frequency and severity of large losses, especially natural catastrophes. - Mortality/morbidity/longevity trends in L&H. - Investment performance and interest-rate environment. - Counterparty demand from primary insurers and distribution via broker relationships (specific partnership details: null).

Swiss Re AG Earnings Call Summary

Earnings Call Date:Aug 14, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted Swiss Re's strong net income and ROE, improved P&C performance, disciplined pricing, and solid investment results. However, these positives were counterbalanced by declines in insurance revenue, challenges in casualty volumes, and negative experience variance in Life & Health Re. Overall, the highlights and lowlights appear balanced.
Q2-2025 Updates
Positive Updates
Strong Net Income and ROE
Swiss Re reported a net income of USD 2.6 billion for the first half of 2025, resulting in an annualized ROE of 23%. This achievement represents approximately 60% of their full-year net income target of more than USD 4.4 billion.
P&C Business Performance
The P&C businesses benefited from a relatively quiet second quarter in terms of large losses, leading to a strong combined ratio. The P&C reserves were bolstered by a USD 300 million nominal reserving in the first half.
Renewals and Pricing Discipline
The company achieved nominal price increases of 2.3% on its overall portfolio during midyear renewals, with significant increases in property and specialty lines, while reducing casualty volumes by 27%.
Life & Health Re Performance
Life & Health Re reported a net income of USD 839 million, slightly above its pro rata target. The largest portfolios, including U.S. mortality, performed in line with expectations.
Investment Results
The company achieved a return on investment (ROI) of 4.1% in the first half, slightly ahead of last year's 4%, with recurring income standing at USD 2 billion.
Capital Strength
Swiss Re's group SST ratio was estimated at 264% as of July 1, 2025, which is 7 points higher than at the start of the year.
Negative Updates
Decline in Group's Insurance Revenue
The group's insurance revenue amounted to USD 20.9 billion in the first half of 2025, down from USD 22.2 billion last year, driven by factors such as the termination of an external retrocession transaction and nonrenewal of certain businesses.
Life & Health Re Experience Variance
The Life & Health Re segment experienced a negative variance of USD 197 million in the first half due to selective assumption updates in onerous business and volume updates, although actual claims experience was slightly positive.
Challenges in Casualty Volume
Casualty volumes were significantly reduced by 27% due to challenges in achieving rate adequacy and risk assessment.
Company Guidance
During Swiss Re's Half Year 2025 Results Conference Call, the company reported a strong net income of USD 2.6 billion for the first half of the year, achieving an annualized ROE of 23%. The progress is attributed to a robust underwriting performance, particularly in the Property & Casualty (P&C) sector, which saw moderate large losses of under USD 150 million in Q2, predominantly from man-made events. This has led to a 60% realization of their USD 4.4 billion full-year net income target. The P&C Re unit posted a new business CSM of USD 2.2 billion, maintaining the same level as the previous year, and a combined ratio of 81.1%, well below their 85% target. Meanwhile, the Life & Health Re unit generated a net income of USD 839 million, slightly surpassing its pro-rata target. Despite facing challenges in some smaller portfolios, the unit remains on track. The company also reported a modest 3% year-to-date volume growth, with a net price change of negative 1.8%, and aims to reduce its cost run rate by USD 100 million this year, contributing to an overall target of USD 300 million by 2027. The group maintains an SST ratio of 264% as of July 1, 2025, reflecting a resilient capital position.

Swiss Re AG Financial Statement Overview

Summary
Financial statements show a strong profitability rebound with materially higher net income and expanding margins, improving ROE, and reduced leverage versus prior peaks. Offsetting this, revenue and cash-flow momentum are somewhat volatile year to year, and cash-flow-to-earnings support appears inconsistent in the provided coverage figures.
Income Statement
74
Positive
Profitability has materially improved versus the loss year in 2020, with net income rising to ~5.0B in 2025 and margins expanding (net margin ~9.9% in 2025 vs ~6.9% in 2024 and ~1.0% in 2022). Revenue growth is strong in 2025 (large jump vs 2024), following steadier growth in 2024 and a decline in 2023—so the trajectory is positive but somewhat volatile. Overall, the earnings rebound and healthier margins are key strengths, while year-to-year revenue swings are the main watch item.
Balance Sheet
72
Positive
Leverage looks moderate for the period with debt-to-equity improving from a high level in 2022 (~0.87) to ~0.36 in 2025, and equity building to ~24.7B. Returns on equity have strengthened meaningfully (ROE ~20% in 2025 vs ~14% in 2023–2024), indicating better capital productivity. The primary risk is balance-sheet variability typical of the sector, with total assets moving notably across years and a prior period (2022) showing elevated leverage.
Cash Flow
63
Positive
Cash generation is solid and steady in absolute terms (operating cash flow ~3.1B in 2024 and ~3.2B in 2025), and free cash flow is consistently positive and roughly in line with net income. However, free cash flow growth has been choppy (down in 2024 vs 2023), and cash-flow-to-earnings support looks inconsistent across years based on the provided coverage figures (including a very low value shown for 2025). Net-net: dependable positive cash flow, but with uneven year-to-year momentum and some coverage volatility in the data.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue50.22B46.76B43.64B46.04B45.94B
Gross Profit50.22B43.14B40.32B38.24B37.70B
EBITDA6.87B4.27B4.26B1.65B3.07B
Net Income4.97B3.24B3.11B472.00M1.44B
Balance Sheet
Total Assets133.92B127.23B133.86B170.68B181.57B
Cash, Cash Equivalents and Short-Term Investments2.74B88.64B91.64B85.61B4.15B
Total Debt8.98B7.26B7.96B11.04B11.19B
Total Liabilities108.64B103.99B111.32B157.87B10.32B
Stockholders Equity24.65B23.11B22.31B12.70B23.57B
Cash Flow
Free Cash Flow3.16B3.13B4.09B2.93B4.10B
Operating Cash Flow3.16B3.13B4.09B2.93B4.10B
Investing Cash Flow-2.38B-407.00M-362.00M-2.34B-2.14B
Financing Cash Flow-2.23B-2.97B-3.22B-1.24B-2.10B

Swiss Re AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price128.00
Price Trends
50DMA
127.72
Positive
100DMA
133.28
Negative
200DMA
138.55
Negative
Market Momentum
MACD
0.37
Positive
RSI
46.59
Neutral
STOCH
42.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SREN, the sentiment is Negative. The current price of 128 is below the 20-day moving average (MA) of 130.14, above the 50-day MA of 127.72, and below the 200-day MA of 138.55, indicating a neutral trend. The MACD of 0.37 indicates Positive momentum. The RSI at 46.59 is Neutral, neither overbought nor oversold. The STOCH value of 42.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:SREN.

Swiss Re AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$80.78B15.2023.97%4.66%-7.33%17.93%
70
Outperform
CHF34.77B5.8014.51%4.49%-4.94%-5.71%
70
Outperform
CHF2.17B5.286.06%3.38%-1.58%4.07%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
59
Neutral
$23.32B20.8312.52%3.80%-1.65%10.05%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:SREN
Swiss Re AG
128.00
-15.94
-11.07%
CH:SLHN
Swiss Life Holding AG
823.80
65.08
8.58%
CH:ZURN
Zurich Insurance Group
540.80
-40.15
-6.91%
CH:VAHN
Vaudoise Assurances Holding SA
741.00
216.24
41.21%

Swiss Re AG Corporate Events

Swiss Re lifts dividend, launches buyback and integrates sustainability in 2025 report
Mar 12, 2026

Swiss Re has released its fully audited 2025 Financial Report, providing detail on group strategy, business performance, risk profile and governance, while for the first time integrating its Sustainability Report into a single publication. The sustainability section outlines progress on strategic ESG goals, climate transition planning and broader social and governance initiatives, underscoring the reinsurer’s push toward integrated financial and non-financial disclosure.

The board is proposing to raise the dividend by 9% to USD 8.00 per share and has launched a share buyback of up to USD 1.5 billion for 2026, moves made against an estimated Swiss Solvency Test ratio of 250% that signal confidence in Swiss Re’s capital strength. Ahead of the 10 April 2026 annual general meeting, the agenda also includes electing Jean-Jacques Henchoz to the board, the departure of Larry Zimpleman, and a planned change of the company’s share capital currency from Swiss francs to U.S. dollars to better align with its business and reduce operating costs.

The most recent analyst rating on (CH:SREN) stock is a Hold with a CHF145.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Swiss Re posts record 2025 profit and unveils USD 1.5 billion buyback
Feb 27, 2026

Swiss Re reported a record 2025 net profit of USD 4.8 billion, up 47% and above its target, driven by strong underwriting in property and casualty lines, lower-than-expected natural catastrophe losses and solid investment returns. The group posted a 19.6% return on equity, a 4.0% investment return and maintained a robust Swiss Solvency Test ratio of about 250%, while P&C Re and Corporate Solutions both met or beat combined ratio targets despite slightly lower insurance revenues.

The company plans to return substantial capital to shareholders via a proposed 9% dividend increase to USD 8.00 per share and a share buyback of up to USD 1.5 billion in 2026, including a USD 500 million sustainable annual programme. Management highlighted that the completion of a portfolio review at Life & Health Re, the exit from the iptiQ business and disciplined renewals in a tougher market should enhance resilience and position all three business units for more consistent earnings, while Board changes include the proposed election of Jean‑Jacques Henchoz and the departure of Larry Zimpleman.

The most recent analyst rating on (CH:SREN) stock is a Sell with a CHF119.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Swiss Re Corporate Solutions Buys QBE’s Global Trade Credit and Surety Business to Expand Credit Offering
Feb 20, 2026

Swiss Re Corporate Solutions, the commercial insurance arm of Swiss Re Group, provides tailored risk transfer and standard insurance products to large and mid-sized corporates worldwide, leveraging the group’s strong balance sheet and global network. The broader Swiss Re Group is a leading global provider of reinsurance, insurance and other risk-transfer solutions, addressing exposures ranging from natural catastrophes and climate change to demographic shifts and cyber risks.

Swiss Re Corporate Solutions has agreed to acquire QBE Insurance Group’s Global Trade Credit and Surety business, a specialised unit with a strong presence in Australia, New Zealand and the U.K. and expected annual revenues of about USD 200 million. The deal, which is subject to regulatory approvals, is set to significantly bolster Swiss Re Corporate Solutions’ direct Credit and Surety offering, deepen its expertise in securing payment and performance risks, and broaden its portfolio in a USD 19 billion market segment that is poised for further growth amid economic uncertainty and increasingly complex supply chains.

By adding QBE’s experienced team and profitable portfolio, Swiss Re Corporate Solutions aims to reinforce its global Credit and Surety platform and differentiate its value proposition to corporate clients seeking sophisticated risk-transfer solutions. The companies plan to collaborate closely through closing to ensure continuity for policyholders, brokers and staff, underscoring Swiss Re’s strategic push to unlock new growth opportunities in an expanding niche of trade-related risk coverage.

The most recent analyst rating on (CH:SREN) stock is a Sell with a CHF119.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Swiss Re Projects Over USD 100 Billion in Insured Losses from Natural Disasters in 2025
Dec 16, 2025

Swiss Re Institute reports that insured losses from natural disasters are projected to exceed USD 100 billion for the sixth consecutive year in 2025, with an estimated total of USD 107 billion. The significant contributors to these losses are wildfires in Los Angeles, which are the most costly on record, and severe thunderstorms in the USA. Despite a decrease from 2024’s USD 141 billion, the persistent rise in insured losses highlights the need for improved prevention and risk management strategies. The USA remains the most affected market, accounting for 83% of global losses due to these events, underscoring the importance of resilience and risk awareness in mitigating future impacts.

The most recent analyst rating on (CH:SREN) stock is a Hold with a CHF133.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 16, 2026